Related Experiment Video
Updated: Mar 2, 2026
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
34.2K
Pathway for the Management of Atrial Fibrillation and Atrial Flutter
Eyal Herzog1, Edgar Argulian, Steven B Levy
1From the Mount Sinai St. Luke's Hospital, New York, NY.
Critical Pathways in Cardiology
|May 17, 2017
Summary
A new RACE pathway simplifies managing atrial fibrillation (AF) and atrial flutter (Afl). It integrates rate control, anticoagulation, cardioversion, and electrophysiology/antiarrhythmic medication for easier diagnosis and treatment.
Area of Science:
- Cardiology
- Clinical Electrophysiology
Background:
- Atrial fibrillation (AF) is a common arrhythmia with increasing prevalence.
- Current AF and atrial flutter (Afl) guidelines are complex and fragmented.
- Existing guidelines are outdated, necessitating an updated management approach.
Purpose of the Study:
- To develop a novel, user-friendly pathway for managing AF and Afl.
- To simplify the diagnosis and initial management of these arrhythmias.
- To provide a comprehensive therapeutic guideline using a structured acronym.
Main Methods:
- Development of the RACE pathway acronym: Rate control, Anticoagulation therapy, Cardioversion, and Electrophysiology/antiarrhythmic medication.
- Incorporation of key concepts for initial diagnosis and management.
- Creation of a comprehensive therapy guideline based on the RACE framework.
Main Results:
- The RACE pathway offers a simplified approach to AF and Afl management.
- It consolidates essential management components into a memorable acronym.
- The pathway aims to improve clinical practice by addressing guideline limitations.
Conclusions:
- The RACE pathway provides a structured and accessible method for managing AF and Afl.
- This novel approach addresses the complexity and fragmentation of existing guidelines.
- The RACE pathway facilitates efficient and effective patient care for these common arrhythmias.
Related Concept Videos
01:25Dysrhythmias VI: Management of Dysrhythmias
547
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
547
01:29Disturbances in Heart Rhythm
3.4K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
3.4K
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
716
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
716
01:29Venous Thrombosis III: Interprofessional Care
426
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
426
01:26Mitral Stenosis III: Medical Management
386
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
386
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.4K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.4K